- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT06566664
Peripheral Neurostimulation
Peripheral nerve blocks are routinely used and highly successful for intra-operative anesthesia and post-operative pain management. Nerve blocks are guided using either neurostimulation as a means to localize the right nerve or by ultrasound guidance or combining the 2 methods. The purpose of this study is to assess whether electrical stimulation improves nerve block quality, beyond its simple purpose of nerve localization.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
The investigators wish to understand how electrical stimulation can affect local anesthetic disposition when performing a peripheral nerve block.
By studying this subject, the investigators open possibilities for improvement on many levels:
increasing the efficacy of the nerve block allows for a reduced onset time, reduced incidence of incomplete block, and prolonged duration of the local anesthetics. This allows for patients to fully benefit from the analgesic properties of the nerve block, allows for a decrease in delays for the operating room readiness, and a allows for a decrease in the amount of medication needed for a successful nerve block. This will decrease side effects and risks of the nerve blocks. Overall better post-surgical pain control may decrease risks for developing chronic post-operative pain, a major post-operative complication.
The results of this study will open the door to novel approaches to manage acute post-operative pain.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
California
-
Stanford, California, Verenigde Staten, 94305
- Stanford University Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Undergoing elective upper limb surgery with a planned brachial plexus nerve block
Exclusion Criteria:
- Under 18 years old
- ASA score above III
- Chronic pain condition with daily milligrams of morphine equivalent > 30
- Poorly controlled psychiatric condition
- Coagulopathy
- Active infection
- Moderate, severe or progressing neuropathy
- COPD/Chronic oxygen user
- Pregnancy
- Incarceration
- Unable to consent
- BMI > 35
- Pacemaker
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Ultrasound-guided brachial plexus block with peripheral nerve stimulation
Patients will receive a brachial plexus catheter with ultrasound guidance as per standard of care, with additional use of the B. Braun HNS 12 nerve stimulator during the loading dose of local anesthesia to maintain a gentle twitch. |
Nerve stimulator that is traditionally used for nerve localization during block placements. |
|
Sham-vergelijker: Ultrasound-guided brachial plexus block without peripheral nerve stimulation
Patients will receive the brachial plexus catheter in the same way the first arm would, and the B Braun nerve stimulator will be placed in the same way, but the ground electrode will not be connected to the patient. |
Stimulator will be placed and turned on, but the grounding electrode will not be connected to prevent nerve stimulation. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Onset of Motor Block
Tijdsspanne: Within 1 hour after the block placement.
|
Determining time when patient experiences first symptoms of local anesthetic action on the upper trunk distribution (median or musculo cutaneous nerve) |
Within 1 hour after the block placement.
|
|
Onset of Sensory Block
Tijdsspanne: Within 1 hour after the block placement.
|
Determining time when patient experiences first symptoms of local anesthetic action on the superior trunk distribution over the shoulder. |
Within 1 hour after the block placement.
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Skin Temperature Change
Tijdsspanne: Immediately before and up to 1 hour after neurostimulation and nerve block is performed.
|
Measuring changes in skin temperature over the course of pre and post stimulation and nerve blocking between the blocked and unblocked arms, measured in degrees Celsius. Using Medline Temperature Sensor. |
Immediately before and up to 1 hour after neurostimulation and nerve block is performed.
|
|
When Patient Experiences First Pain
Tijdsspanne: up to day 7 post operatively
|
Time after surgery at which the patient experiences first sign of pain at the surgical site, as measured by the time for first local anesthetic bolus based on pump device history. |
up to day 7 post operatively
|
|
Time of First Opioid Taken
Tijdsspanne: Within the first 7 days after surgery
|
As measured by asking patients if they were taking opioids daily after surgery, up to one week. |
Within the first 7 days after surgery
|
|
Total Post Operative MME/Opioid Usage at Day 1
Tijdsspanne: On Post Operative Day 1
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 1
|
|
Total Post Operative MME/Opioid Usage at Day 2
Tijdsspanne: On Post Operative Day 2
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 2
|
|
Total Post Operative MME Opioid Usage at Day 3
Tijdsspanne: On Post Operative Day 3
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 3
|
|
Total Post Operative MME Opioid Usage at Day 4
Tijdsspanne: On Post Operative Day 4
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 4
|
|
Total Post Operative MME Opioid Usage at Day 5
Tijdsspanne: On Post Operative Day 5
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 5
|
|
Total Post Operative MME Opioid Usage at Day 6
Tijdsspanne: On Post Operative Day 6
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 6
|
|
Opioid Usage Assessment at Day 7
Tijdsspanne: On Post Operative Day 7
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 7
|
|
Opioid Usage Assessment at Day 28
Tijdsspanne: On Post Operative Day 28
|
Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 3 weeks and 2) if so, how many pills per day. |
On Post Operative Day 28
|
|
Opioid Usage Assessment at 6 Months
Tijdsspanne: On Post Operative Month 6
|
Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 5 months and 2) if so, how many pills per day. |
On Post Operative Month 6
|
|
Opioid Usage Assessment at 1 Year
Tijdsspanne: On Post Operative 1 Year
|
Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 6 months and 2) if so, how many pills per day. |
On Post Operative 1 Year
|
|
Quality of Recovery
Tijdsspanne: At Post Operative days 7 and 28 , 6 months, and 1 year
|
Using the standardized -Quality of Recovery 15- at post operative days 7 and 28, 6 months, and 1 year. Each item count on a 0-10 scale where 0 is worst and 10 is best. PART A How have you been feeling in the last 24 hours? (0 to 10, where 0 = none of the time [poor] and 10 = all of the time [excellent]) Q.1 Able to breathe easily Q.2 Been able to enjoy food Q.3 Feeling rested Q.4 Have had a good sleep Q.5 Able to look after personal toilet and hygiene unaided Q.6 Able to communicate with family or friends Q.7 Getting support from hospital doctors and nurses Q.8 Able to return to work or usual home activities Q.9 Feeling comfortable and in control Q.10 Having a feeling of general well-being PART B Have you had any of the following in the last 24 hours? (10 to 0, where 10 = none of the time [excellent] and 0 = all of the time [poor]) Q.11 Moderate pain Q.12 Severe pain Q.13 Nausea or vomiting Q.14 Feeling worried or anxious Q.15 Feeling sad or depressed |
At Post Operative days 7 and 28 , 6 months, and 1 year
|
|
General satisfaction
Tijdsspanne: At post operative days 0, 1, 7, 28, 6 months, and 1 year
|
General satisfaction on a scale from 1-5 (extremely unsatisfied, unsatisfied, neutral, satisfy, extremely satisfied). Asking patients if they would receive the block again (Y/N). |
At post operative days 0, 1, 7, 28, 6 months, and 1 year
|
|
Adverse Events
Tijdsspanne: Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.
|
Numbness, Weakness, Tingling, Breathing Difficulties, Hoarseness |
Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.
|
|
Catheter Duration Before Discontinuation
Tijdsspanne: After surgery, up until catheter discontinuation.
|
Patients' catheter duration before discontinuation, as measured by Avoset pump device data. |
After surgery, up until catheter discontinuation.
|
|
Total Local Anesthetic Use with Catheter
Tijdsspanne: After surgery, up until catheter discontinuation.
|
Patients' local anesthetic use with catheter, as measured by Avoset pump device data. |
After surgery, up until catheter discontinuation.
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 76523
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .